Health Care & Life Sciences » Biotechnology | Bellicum Pharmaceuticals Inc.

Bellicum Pharmaceuticals Inc. | Ownership

Companies that own Bellicum Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baker Bros. Advisors LP
4,093,447
9.44%
-58,131
0.19%
06/30/2018
BlackRock Fund Advisors
2,901,007
6.69%
762,914
0%
06/30/2018
Farallon Capital Management LLC
2,000,000
4.61%
2,000,000
0.1%
06/30/2018
The Vanguard Group, Inc.
1,859,002
4.29%
553,856
0%
06/30/2018
Fidelity Management & Research Co.
1,851,555
4.26%
-143,117
0%
06/30/2018
JPMorgan Investment Management, Inc.
1,618,514
3.73%
560,438
0%
06/30/2018
JPMorgan Asset Management (UK) Ltd.
1,557,427
3.59%
120,303
0.01%
06/30/2018
Wasatch Advisors, Inc.
923,824
2.13%
840,175
0.04%
06/30/2018
Millennium Management LLC
733,850
1.69%
487,982
0.01%
06/30/2018
SSgA Funds Management, Inc.
647,709
1.49%
197,377
0%
06/30/2018

About Bellicum Pharmaceuticals

View Profile
Address
Life Science Plaza
Houston Texas 77030
United States
Employees -
Website http://www.bellicum.com
Updated 07/08/2019
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.